Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
3.040
-0.110 (-3.49%)
At close: Feb 4, 2025, 4:00 PM
3.014
-0.026 (-0.86%)
After-hours: Feb 4, 2025, 7:49 PM EST
Solid Biosciences Employees
Solid Biosciences had 88 employees as of December 31, 2023. The number of employees increased by 1 or 1.15% compared to the previous year.
Employees
88
Change (1Y)
1
Growth (1Y)
1.15%
Revenue / Employee
n/a
Profits / Employee
-$1,164,045
Market Cap
121.46M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
SLDB News
- 14 days ago - Solid Biosciences: Differentiating Factors Of SGT-212 To Set Itself Apart - Seeking Alpha
- 14 days ago - Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich's Ataxia - GlobeNewsWire
- 20 days ago - Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic Medicines - GlobeNewsWire
- 27 days ago - Solid Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich's Ataxia - GlobeNewsWire
- 6 weeks ago - Solid Biosciences Added to the Nasdaq Biotechnology Index - GlobeNewsWire
- 7 weeks ago - Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst - Benzinga
- 2 months ago - Solid Biosciences to Participate at Upcoming Investor Conferences - GlobeNewsWire